InSitu Biologics, Inc. funding
InSitu Biologics, Inc., a biotechnology company based in Oakdale, MN, filed a Form D with the SEC on August 10, 2026 and reported $1.3M raised of a $2.5M offering. It filed 2 new offerings in this period, totaling $5.2M.
Amount raised$1.3M
Offering size$2.5M
Filed with the SECAugust 10, 2026
First saleAugust 4, 2026
IndustryBiotechnology
SecuritiesDebt, Other
LocationOakdale, MN
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment$2.5M
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 10
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| August 10, 2026 | $1.3M | $2.5M | Debt, Other |
| December 18, 2025 | $4M | $8M | Equity |
Other health care rounds in Minnesota
AngioInsight, Inc.$16.3M · Nov 10Other Health CareEvia Bio, Inc.$5.5M · Sep 28BiotechnologyMedical 21, Inc.$550K · Oct 23BiotechnologyPelvital USA, Inc.$520K · Oct 5Other Health CareAllina Health Surgery Center - Brooklyn Park, LLC$135K · Nov 4Other Health CareSurgicare of Minneapolis, Ltd.$0 · Oct 8Other Health Care